English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 111 | Tables: 118 | Medical Care
The global Donor Transfusion Diagnosis market was valued at US$ 2300 million in 2025 and is anticipated to reach US$ 4178 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
The gross profit margin of major companies in the industry is between 40%–60%.
Donor Transfusion Diagnosis refers to laboratory diagnostic testing performed to evaluate blood donors and ensure compatibility and safety in blood transfusion procedures. These tests are designed to detect infectious diseases, determine blood group compatibility, and screen for antibodies that may affect transfusion outcomes. Diagnostic methods typically include immunohematology testing, nucleic acid testing, and serological assays. These diagnostic procedures are critical for ensuring safe blood supply in hospitals and blood banks, preventing transfusion reactions, and reducing the risk of disease transmission through donated blood.
The industrial chain includes upstream diagnostic reagents, laboratory instruments, blood testing kits, and sample collection materials. Midstream processes involve laboratory testing, blood typing analysis, infection screening, and clinical validation. Downstream users include blood banks, hospitals, clinical laboratories, and healthcare systems responsible for blood transfusion management. Supporting services include laboratory quality control, data management systems, and regulatory compliance programs.
The donor transfusion diagnosis market is expanding due to increasing global demand for safe blood transfusion and improved healthcare systems. Rising awareness of blood safety and the need for accurate screening of infectious diseases are driving the adoption of advanced diagnostic technologies. Technological developments in nucleic acid testing and automated laboratory systems are improving detection sensitivity and testing efficiency. Healthcare institutions are investing in modern diagnostic platforms to ensure reliable blood compatibility testing and regulatory compliance. However, regulatory requirements and the cost of advanced diagnostic technologies may influence market adoption in certain regions. Overall, the growing demand for blood transfusion services and improved diagnostic capabilities is expected to support steady growth in the donor transfusion diagnosis market.
This report delivers a comprehensive overview of the global Donor Transfusion Diagnosis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Donor Transfusion Diagnosis. The Donor Transfusion Diagnosis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Donor Transfusion Diagnosis market comprehensively. Regional market sizes by Type, by Application, by Test Target, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Donor Transfusion Diagnosis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Grifols
F. Hoffmann-La Roche
Abbott
Bio-Rad Laboratories
Werfen
QuidelOrtho Corporation
AliveDx Holdings Finance
BAG Diagnostics GmbH
Diasorin
Prestige Diagnostics
Atlas Medical GmbH
Lorne Laboratories
Segment by Type
Instruments
Kits and Reagents
Segment by Test Target
Blood Type Identification
Infectious Disease Screening
Antibody Screening
Segment by Equipment Type
Automated Blood Testing System
Manual Diagnostic Kit
Integrated Blood Analysis System
Segment by Application
Blood Banks
Blood Donation/Transfusion Centers
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Test Target, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Donor Transfusion Diagnosis companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Donor Transfusion Diagnosis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Instruments
1.2.3 Kits and Reagents
1.3 Market by Test Target
1.3.1 Global Donor Transfusion Diagnosis Market Size Growth Rate by Test Target: 2021 vs 2025 vs 2032
1.3.2 Blood Type Identification
1.3.3 Infectious Disease Screening
1.3.4 Antibody Screening
1.4 Market by Equipment Type
1.4.1 Global Donor Transfusion Diagnosis Market Size Growth Rate by Equipment Type: 2021 vs 2025 vs 2032
1.4.2 Automated Blood Testing System
1.4.3 Manual Diagnostic Kit
1.4.4 Integrated Blood Analysis System
1.5 Market by Application
1.5.1 Global Donor Transfusion Diagnosis Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Blood Banks
1.5.3 Blood Donation/Transfusion Centers
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Donor Transfusion Diagnosis Market Perspective (2021–2032)
2.2 Global Donor Transfusion Diagnosis Growth Trends by Region
2.2.1 Global Donor Transfusion Diagnosis Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Donor Transfusion Diagnosis Historic Market Size by Region (2021–2026)
2.2.3 Donor Transfusion Diagnosis Forecasted Market Size by Region (2027–2032)
2.3 Donor Transfusion Diagnosis Market Dynamics
2.3.1 Donor Transfusion Diagnosis Industry Trends
2.3.2 Donor Transfusion Diagnosis Market Drivers
2.3.3 Donor Transfusion Diagnosis Market Challenges
2.3.4 Donor Transfusion Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Donor Transfusion Diagnosis Players by Revenue
3.1.1 Global Top Donor Transfusion Diagnosis Players by Revenue (2021–2026)
3.1.2 Global Donor Transfusion Diagnosis Revenue Market Share by Players (2021–2026)
3.2 Global Top Donor Transfusion Diagnosis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Donor Transfusion Diagnosis Revenue
3.4 Global Donor Transfusion Diagnosis Market Concentration Ratio
3.4.1 Global Donor Transfusion Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Donor Transfusion Diagnosis Revenue in 2025
3.5 Global Key Players of Donor Transfusion Diagnosis Head Offices and Areas Served
3.6 Global Key Players of Donor Transfusion Diagnosis, Products and Applications
3.7 Global Key Players of Donor Transfusion Diagnosis, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Donor Transfusion Diagnosis Breakdown Data by Type
4.1 Global Donor Transfusion Diagnosis Historic Market Size by Type (2021–2026)
4.2 Global Donor Transfusion Diagnosis Forecasted Market Size by Type (2027–2032)
5 Donor Transfusion Diagnosis Breakdown Data by Application
5.1 Global Donor Transfusion Diagnosis Historic Market Size by Application (2021–2026)
5.2 Global Donor Transfusion Diagnosis Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Donor Transfusion Diagnosis Market Size (2021–2032)
6.2 North America Donor Transfusion Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Donor Transfusion Diagnosis Market Size by Country (2021–2026)
6.4 North America Donor Transfusion Diagnosis Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Donor Transfusion Diagnosis Market Size (2021–2032)
7.2 Europe Donor Transfusion Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Donor Transfusion Diagnosis Market Size by Country (2021–2026)
7.4 Europe Donor Transfusion Diagnosis Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Donor Transfusion Diagnosis Market Size (2021–2032)
8.2 Asia-Pacific Donor Transfusion Diagnosis Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Donor Transfusion Diagnosis Market Size by Region (2021–2026)
8.4 Asia-Pacific Donor Transfusion Diagnosis Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Donor Transfusion Diagnosis Market Size (2021–2032)
9.2 Latin America Donor Transfusion Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Donor Transfusion Diagnosis Market Size by Country (2021–2026)
9.4 Latin America Donor Transfusion Diagnosis Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Donor Transfusion Diagnosis Market Size (2021–2032)
10.2 Middle East & Africa Donor Transfusion Diagnosis Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Donor Transfusion Diagnosis Market Size by Country (2021–2026)
10.4 Middle East & Africa Donor Transfusion Diagnosis Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Donor Transfusion Diagnosis Introduction
11.1.4 Grifols Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.1.5 Grifols Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Donor Transfusion Diagnosis Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Donor Transfusion Diagnosis Introduction
11.3.4 Abbott Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.3.5 Abbott Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Donor Transfusion Diagnosis Introduction
11.4.4 Bio-Rad Laboratories Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Werfen
11.5.1 Werfen Company Details
11.5.2 Werfen Business Overview
11.5.3 Werfen Donor Transfusion Diagnosis Introduction
11.5.4 Werfen Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.5.5 Werfen Recent Development
11.6 QuidelOrtho Corporation
11.6.1 QuidelOrtho Corporation Company Details
11.6.2 QuidelOrtho Corporation Business Overview
11.6.3 QuidelOrtho Corporation Donor Transfusion Diagnosis Introduction
11.6.4 QuidelOrtho Corporation Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.6.5 QuidelOrtho Corporation Recent Development
11.7 AliveDx Holdings Finance
11.7.1 AliveDx Holdings Finance Company Details
11.7.2 AliveDx Holdings Finance Business Overview
11.7.3 AliveDx Holdings Finance Donor Transfusion Diagnosis Introduction
11.7.4 AliveDx Holdings Finance Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.7.5 AliveDx Holdings Finance Recent Development
11.8 BAG Diagnostics GmbH
11.8.1 BAG Diagnostics GmbH Company Details
11.8.2 BAG Diagnostics GmbH Business Overview
11.8.3 BAG Diagnostics GmbH Donor Transfusion Diagnosis Introduction
11.8.4 BAG Diagnostics GmbH Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.8.5 BAG Diagnostics GmbH Recent Development
11.9 Diasorin
11.9.1 Diasorin Company Details
11.9.2 Diasorin Business Overview
11.9.3 Diasorin Donor Transfusion Diagnosis Introduction
11.9.4 Diasorin Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.9.5 Diasorin Recent Development
11.10 Prestige Diagnostics
11.10.1 Prestige Diagnostics Company Details
11.10.2 Prestige Diagnostics Business Overview
11.10.3 Prestige Diagnostics Donor Transfusion Diagnosis Introduction
11.10.4 Prestige Diagnostics Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.10.5 Prestige Diagnostics Recent Development
11.11 Atlas Medical GmbH
11.11.1 Atlas Medical GmbH Company Details
11.11.2 Atlas Medical GmbH Business Overview
11.11.3 Atlas Medical GmbH Donor Transfusion Diagnosis Introduction
11.11.4 Atlas Medical GmbH Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.11.5 Atlas Medical GmbH Recent Development
11.12 Lorne Laboratories
11.12.1 Lorne Laboratories Company Details
11.12.2 Lorne Laboratories Business Overview
11.12.3 Lorne Laboratories Donor Transfusion Diagnosis Introduction
11.12.4 Lorne Laboratories Revenue in Donor Transfusion Diagnosis Business (2021–2026)
11.12.5 Lorne Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Donor Transfusion Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Instruments
Table 3. Key Players of Kits and Reagents
Table 4. Global Donor Transfusion Diagnosis Market Size Growth Rate by Test Target (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Blood Type Identification
Table 6. Key Players of Infectious Disease Screening
Table 7. Key Players of Antibody Screening
Table 8. Global Donor Transfusion Diagnosis Market Size Growth Rate by Equipment Type (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Automated Blood Testing System
Table 10. Key Players of Manual Diagnostic Kit
Table 11. Key Players of Integrated Blood Analysis System
Table 12. Global Donor Transfusion Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Donor Transfusion Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Donor Transfusion Diagnosis Market Size by Region (US$ Million), 2021–2026
Table 15. Global Donor Transfusion Diagnosis Market Share by Region (2021–2026)
Table 16. Global Donor Transfusion Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032
Table 17. Global Donor Transfusion Diagnosis Market Share by Region (2027–2032)
Table 18. Donor Transfusion Diagnosis Market Trends
Table 19. Donor Transfusion Diagnosis Market Drivers
Table 20. Donor Transfusion Diagnosis Market Challenges
Table 21. Donor Transfusion Diagnosis Market Restraints
Table 22. Global Donor Transfusion Diagnosis Revenue by Players (US$ Million), 2021–2026
Table 23. Global Donor Transfusion Diagnosis Market Share by Players (2021–2026)
Table 24. Global Top Donor Transfusion Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Donor Transfusion Diagnosis Revenue, 2025
Table 25. Ranking of Global Top Donor Transfusion Diagnosis Companies by Revenue (US$ Million) in 2025
Table 26. Global 5 Largest Players Market Share by Donor Transfusion Diagnosis Revenue (CR5 and HHI), 2021–2026
Table 27. Global Key Players of Donor Transfusion Diagnosis, Headquarters and Area Served
Table 28. Global Key Players of Donor Transfusion Diagnosis, Products and Applications
Table 29. Global Key Players of Donor Transfusion Diagnosis, Date of General Availability (GA)
Table 30. Mergers and Acquisitions, Expansion Plans
Table 31. Global Donor Transfusion Diagnosis Market Size by Type (US$ Million), 2021–2026
Table 32. Global Donor Transfusion Diagnosis Revenue Market Share by Type (2021–2026)
Table 33. Global Donor Transfusion Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032
Table 34. Global Donor Transfusion Diagnosis Revenue Market Share by Type (2027–2032)
Table 35. Global Donor Transfusion Diagnosis Market Size by Application (US$ Million), 2021–2026
Table 36. Global Donor Transfusion Diagnosis Revenue Market Share by Application (2021–2026)
Table 37. Global Donor Transfusion Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032
Table 38. Global Donor Transfusion Diagnosis Revenue Market Share by Application (2027–2032)
Table 39. North America Donor Transfusion Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. North America Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 41. North America Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 42. Europe Donor Transfusion Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Europe Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 44. Europe Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 45. Asia-Pacific Donor Transfusion Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 46. Asia-Pacific Donor Transfusion Diagnosis Market Size by Region (US$ Million), 2021–2026
Table 47. Asia-Pacific Donor Transfusion Diagnosis Market Size by Region (US$ Million), 2027–2032
Table 48. Latin America Donor Transfusion Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Latin America Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 50. Latin America Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 51. Middle East & Africa Donor Transfusion Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Middle East & Africa Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 53. Middle East & Africa Donor Transfusion Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 54. Grifols Company Details
Table 55. Grifols Business Overview
Table 56. Grifols Donor Transfusion Diagnosis Product
Table 57. Grifols Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 58. Grifols Recent Development
Table 59. F. Hoffmann-La Roche Company Details
Table 60. F. Hoffmann-La Roche Business Overview
Table 61. F. Hoffmann-La Roche Donor Transfusion Diagnosis Product
Table 62. F. Hoffmann-La Roche Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 63. F. Hoffmann-La Roche Recent Development
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Donor Transfusion Diagnosis Product
Table 67. Abbott Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 68. Abbott Recent Development
Table 69. Bio-Rad Laboratories Company Details
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories Donor Transfusion Diagnosis Product
Table 72. Bio-Rad Laboratories Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 73. Bio-Rad Laboratories Recent Development
Table 74. Werfen Company Details
Table 75. Werfen Business Overview
Table 76. Werfen Donor Transfusion Diagnosis Product
Table 77. Werfen Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 78. Werfen Recent Development
Table 79. QuidelOrtho Corporation Company Details
Table 80. QuidelOrtho Corporation Business Overview
Table 81. QuidelOrtho Corporation Donor Transfusion Diagnosis Product
Table 82. QuidelOrtho Corporation Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 83. QuidelOrtho Corporation Recent Development
Table 84. AliveDx Holdings Finance Company Details
Table 85. AliveDx Holdings Finance Business Overview
Table 86. AliveDx Holdings Finance Donor Transfusion Diagnosis Product
Table 87. AliveDx Holdings Finance Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 88. AliveDx Holdings Finance Recent Development
Table 89. BAG Diagnostics GmbH Company Details
Table 90. BAG Diagnostics GmbH Business Overview
Table 91. BAG Diagnostics GmbH Donor Transfusion Diagnosis Product
Table 92. BAG Diagnostics GmbH Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 93. BAG Diagnostics GmbH Recent Development
Table 94. Diasorin Company Details
Table 95. Diasorin Business Overview
Table 96. Diasorin Donor Transfusion Diagnosis Product
Table 97. Diasorin Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 98. Diasorin Recent Development
Table 99. Prestige Diagnostics Company Details
Table 100. Prestige Diagnostics Business Overview
Table 101. Prestige Diagnostics Donor Transfusion Diagnosis Product
Table 102. Prestige Diagnostics Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 103. Prestige Diagnostics Recent Development
Table 104. Atlas Medical GmbH Company Details
Table 105. Atlas Medical GmbH Business Overview
Table 106. Atlas Medical GmbH Donor Transfusion Diagnosis Product
Table 107. Atlas Medical GmbH Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 108. Atlas Medical GmbH Recent Development
Table 109. Lorne Laboratories Company Details
Table 110. Lorne Laboratories Business Overview
Table 111. Lorne Laboratories Donor Transfusion Diagnosis Product
Table 112. Lorne Laboratories Revenue in Donor Transfusion Diagnosis Business (US$ Million), 2021–2026
Table 113. Lorne Laboratories Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Donor Transfusion Diagnosis Picture
Figure 2. Global Donor Transfusion Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Donor Transfusion Diagnosis Market Share by Type: 2025 vs 2032
Figure 4. Instruments Features
Figure 5. Kits and Reagents Features
Figure 6. Global Donor Transfusion Diagnosis Market Size Comparison by Test Target (US$ Million), 2021–2032
Figure 7. Blood Type Identification Features
Figure 8. Infectious Disease Screening Features
Figure 9. Antibody Screening Features
Figure 10. Global Donor Transfusion Diagnosis Market Size Comparison by Equipment Type (US$ Million), 2021–2032
Figure 11. Automated Blood Testing System Features
Figure 12. Manual Diagnostic Kit Features
Figure 13. Integrated Blood Analysis System Features
Figure 14. Global Donor Transfusion Diagnosis Market Size by Application (US$ Million), 2021–2032
Figure 15. Global Donor Transfusion Diagnosis Market Share by Application: 2025 vs 2032
Figure 16. Blood Banks Case Studies
Figure 17. Blood Donation/Transfusion Centers Case Studies
Figure 18. Others Case Studies
Figure 19. Donor Transfusion Diagnosis Report Years Considered
Figure 20. Global Donor Transfusion Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 21. Global Donor Transfusion Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Donor Transfusion Diagnosis Market Share by Region: 2025 vs 2032
Figure 23. Global Donor Transfusion Diagnosis Market Share by Players in 2025
Figure 24. Global Donor Transfusion Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. The Top 10 and 5 Players Market Share by Donor Transfusion Diagnosis Revenue in 2025
Figure 26. North America Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. North America Donor Transfusion Diagnosis Market Share by Country (2021–2032)
Figure 28. United States Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Canada Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Europe Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Donor Transfusion Diagnosis Market Share by Country (2021–2032)
Figure 32. Germany Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. France Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. U.K. Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Italy Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Russia Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Ireland Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Asia-Pacific Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Donor Transfusion Diagnosis Market Share by Region (2021–2032)
Figure 40. China Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Japan Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. South Korea Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Southeast Asia Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. India Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Australia & New Zealand Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Latin America Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Donor Transfusion Diagnosis Market Share by Country (2021–2032)
Figure 48. Mexico Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Brazil Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Middle East & Africa Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Donor Transfusion Diagnosis Market Share by Country (2021–2032)
Figure 52. Israel Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Saudi Arabia Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. UAE Donor Transfusion Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Grifols Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 57. Abbott Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 59. Werfen Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 60. QuidelOrtho Corporation Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 61. AliveDx Holdings Finance Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 62. BAG Diagnostics GmbH Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 63. Diasorin Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 64. Prestige Diagnostics Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 65. Atlas Medical GmbH Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 66. Lorne Laboratories Revenue Growth Rate in Donor Transfusion Diagnosis Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
